- cafead   Dec 15, 2023 at 09:52: AM
via With the gold rush in obesity meds showing no sign of abating, Fractyl Health is gearing up to go public as it gathers preclinical evidence that its GLP-1 gene therapy could take on Novo Nordisk’s Wegovy.
article source
article source